This Funding Opportunity Announcement (FOA) is associated with the Beau Biden Cancer MoonshotSM Initiative established to accelerate cancer research.
Specifically, this FOA targets the following area designated as a scientific priority by the Blue Ribbon Panel (BRP):
the Implementation of Integrated
and Evidenced-based Symptom Management Throughout the Cancer Trajectory.
The purpose of this specific FOA is to promote research on the implementation and evaluation of integrated symptom monitoring and management systems for use in cancer care delivery through a Research Consortium.
This research will provide new insights and valuable evidence that can be used to guide efforts on a nation-wide basis to improve symptom control for cancer patients during treatment and survivorship.